AI-generated summary
In this randomized controlled trial, cancer survivors with fatigue used a light device daily for 30 minutes over 28 days, receiving either bright white light or dim red light as an active control. The authors report that bright white light was associated with a 17% greater reduction in fatigue than dim red light, and both groups improved on mood, depressive symptoms and quality of life. The trial was small and the abstract does not report a sham or placebo-matched control beyond dim red light.
- Participants
- 81
- Who or what was studied
- Cancer survivors who met diagnostic criteria for cancer-related fatigue
- Limits stated in the abstract
- The abstract reports a single small trial with a modest between-group effect (d = .30) and an active rather than inert control condition.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Randomized controlled trial, Bright light therapy, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.